| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0025-7125(05)70211-X |
| P698 | PubMed publication ID | 10685132 |
| P2093 | author name string | Ridker PM | |
| Morrow DA | |||
| P2860 | cites work | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 |
| Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes | Q24339405 | ||
| Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque | Q24339425 | ||
| Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor) | Q24634292 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man | Q28359675 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q34064191 | ||
| Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women | Q34067367 | ||
| Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice | Q34229709 | ||
| Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 | ||
| Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology | Q34308581 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids | Q35809793 | ||
| Cytokine regulation of endothelial cell function. | Q36142433 | ||
| C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study | Q36598316 | ||
| Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi | Q36745409 | ||
| Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation | Q37926154 | ||
| Leukocyte adhesion to endothelium in inflammation | Q37938615 | ||
| Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications | Q38648794 | ||
| Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension | Q39758349 | ||
| Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor | Q39760201 | ||
| Genetic manipulation of vascular adhesion molecules in mice | Q39773554 | ||
| Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina | Q39817564 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Monocyte adhesion and transmigration in atherosclerosis. | Q40760531 | ||
| Homocysteine and risk of cardiovascular disease among postmenopausal women | Q40812338 | ||
| C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 | ||
| C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction | Q40857092 | ||
| Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease | Q40868032 | ||
| Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 | ||
| Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors | Q40922775 | ||
| Statins do more than just lower cholesterol | Q41169571 | ||
| The unstable atheroma | Q41627468 | ||
| Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. | Q42473074 | ||
| Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion | Q42494764 | ||
| Inflammation in ischaemic heart disease | Q43187895 | ||
| Angiographic morphology and the pathogenesis of unstable angina pectoris | Q43734967 | ||
| Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. | Q44082955 | ||
| Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
| Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. | Q45191938 | ||
| Antiatherothrombotic properties of statins: implications for cardiovascular event reduction | Q48011361 | ||
| Inflammation in cardiovascular disease: cart, horse, or both? | Q48018364 | ||
| Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol. | Q50865979 | ||
| Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. | Q50866439 | ||
| Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. | Q50950290 | ||
| Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. | Q52526594 | ||
| The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction | Q57636423 | ||
| Elevated Levels of Interleukin-6 in Unstable Angina | Q58230354 | ||
| Transient intermittent lymphocyte activation is responsible for the instability of angina | Q58464956 | ||
| Monocytic origin of foam cells in human atherosclerotic plaques | Q61651815 | ||
| Antioxidants and atherosclerosis. A current assessment | Q67962768 | ||
| Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human Atheroma | Q68352602 | ||
| Elevation of C-reactive protein in "active" coronary artery disease | Q68696120 | ||
| Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques | Q69374705 | ||
| Macrophages and atherogenesis | Q69901729 | ||
| Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy | Q70058590 | ||
| Effect of active oxygen species on intimal proliferation in rat aorta after arterial injury | Q71005312 | ||
| Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial | Q71512983 | ||
| Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro | Q71703868 | ||
| Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitro | Q71857077 | ||
| Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes | Q71958321 | ||
| Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture | Q72092927 | ||
| Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis | Q72629803 | ||
| Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
| Association of coronary plaque rupture and atherosclerotic inflammation | Q73158920 | ||
| Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall | Q73284558 | ||
| Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse | Q74582629 | ||
| Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum | Q77634439 | ||
| Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators | Q78017116 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 149-61, ix | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | C-reactive protein, inflammation, and coronary risk | |
| P478 | volume | 84 |
| Q44586541 | A two-step genetic study on quantitative precursors of coronary artery disease in a homogeneous Indian population: case-control association discovery and validation by transmission-disequilibrium test |
| Q24797866 | Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation |
| Q37340088 | Aldosterone Receptor Antagonism Reduces Urinary C-Reactive Protein Excretion in Angiotensin II-Infused, Hypertensive Rats |
| Q35139924 | Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood |
| Q39051784 | Anti-inflammatory drugs as promising cardiovascular treatments. |
| Q51137795 | Association of serum leptin with serum C-reactive protein in hemodialysis patients. |
| Q44434968 | Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus |
| Q34427770 | Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia |
| Q38285387 | Avocado oil supplementation modifies cardiovascular risk profile markers in a rat model of sucrose-induced metabolic changes. |
| Q50196870 | Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial. |
| Q28165737 | C-Reactive Protein, Antiinflammatory Drugs, and Quality of Life in Diabetes |
| Q28200344 | C-reactive protein (CRP)-lowering agents |
| Q37870054 | C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction |
| Q34397073 | C-reactive protein, inflammation, and innate immunity |
| Q44507817 | Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia |
| Q40628986 | Development of a high sensitivity C-reactive protein immunoassay and comparison with a commercial kit. |
| Q30491678 | Dietary patterns are linked to cardiovascular risk factors but not to inflammatory markers in Alaska Eskimos |
| Q36495408 | Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). |
| Q26785938 | Effects of Olive Oil on Markers of Inflammation and Endothelial Function-A Systematic Review and Meta-Analysis |
| Q34675610 | Effects of high versus low-dose atorvastatin on high sensitive C-reactive protein in acute coronary syndrome |
| Q46101255 | Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients. |
| Q73935874 | Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects |
| Q51326584 | Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery. |
| Q35554016 | Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. |
| Q35202147 | Inflammatory pathways in children with insufficient or disordered sleep |
| Q38482057 | Inhaled corticosteroid use in asthma and the prevention of myocardial infarction |
| Q31143614 | Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study |
| Q35576098 | Laboratory Tests in Diagnosis and Management of Diabetes Mellitus. Practical Considerations |
| Q34227152 | Lipid-lowering drugs in lupus: an unexplored therapeutic intervention |
| Q44198614 | Mediterranean diet and inflammatory response in myocardial infarction survivors |
| Q35062342 | Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination |
| Q34604324 | Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease |
| Q44908496 | Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis |
| Q34773911 | Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin |
| Q51464560 | Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. |
| Q39658010 | Relationship of destructive periodontal disease to the acute-phase response |
| Q28241987 | Stress and health: psychological, behavioral, and biological determinants |
| Q34592629 | Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A |
| Q33941972 | Systemic inflammation in cardiovascular and periodontal disease: comparative study |
| Q35738921 | The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases |
| Q34552829 | The antimicrobial activity of C-reactive protein |
| Q46244173 | The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women |
| Q43208407 | The metabolic profile in patients with skin tags |
| Q53441808 | The relationship between attendance at religious services and cardiovascular inflammatory markers. |
| Q43554855 | The relationship between religious service attendance and coronary heart disease and related risk factors in Saskatchewan, Canada |
| Q34590826 | The role of C-reactive protein as a prognostic indicator in advanced cancer |
| Q35080677 | The role of infection in the pathogenesis of cardiovascular disease |
Search more.